Loading organizations...

§ Venture Capital · USA
This VC firm invests in early-stage software companies in healthcare, commerce, and enterprise sectors, focusing on innovative online solutions for tradition...
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
Key people at LionBird.
LionBird was founded in 2012 by Haymi Behar (Advising Founder).
LionBird is a venture capital firm specializing in early-stage investments in software companies, primarily focusing on healthcare, commerce, and enterprise sectors. Their mission centers on empowering startups that deliver innovative online solutions to address market inefficiencies and unlock new opportunities. LionBird combines capital investment with strategic guidance and operational support to help entrepreneurs navigate growth challenges and scale effectively. The firm is particularly committed to transformative businesses that reset healthcare's relationship with technology and foster innovation in other key sectors, thereby contributing significantly to the startup ecosystem by nurturing visionary ideas and fostering a thriving environment for groundbreaking startups[1][2][4].
Founded in 2012 and headquartered in Tel Aviv, Israel, with additional offices in the United States, LionBird was established by experienced investment professionals and entrepreneurs with deep expertise in technology and healthcare sectors. The firm evolved with a thematic investment strategy focused on early-stage software startups exhibiting disruptive technologies and visionary leadership. Over time, LionBird has built a reputation for a rigorous selection process and an operator-first approach, emphasizing strong partnerships with entrepreneurs and active involvement in their portfolio companies’ growth. This evolution reflects their commitment to supporting startups from seed stages through significant growth phases, with notable portfolio successes including companies like Cybereason, Wrike, and Snyk[2][1].
LionBird rides the wave of digital transformation in healthcare and enterprise software, sectors undergoing rapid innovation driven by AI, cloud computing, and data analytics. The timing is crucial as healthcare systems globally seek technology-driven solutions to improve outcomes and reduce costs, while commerce and enterprise sectors demand scalable, efficient software platforms. Market forces such as increased healthcare digitization, regulatory shifts, and growing demand for remote and cloud-based solutions favor LionBird’s investment thesis. By backing startups that reset traditional industry paradigms, LionBird influences the broader ecosystem by accelerating the adoption of innovative technologies and fostering a new generation of tech-enabled companies that challenge incumbents[1][2][4].
Looking ahead, LionBird is poised to deepen its focus on healthcare technology and enterprise software, leveraging emerging trends like AI-driven clinical decision support, digital therapeutics, and cloud-native enterprise platforms. Their influence is likely to expand as they continue to back startups that combine technological innovation with social impact, aligning with growing investor and market emphasis on responsible innovation. The firm’s operator-first model and strong network position it well to identify and scale the next wave of transformative companies, potentially shaping the future of healthcare and commerce technology ecosystems globally[1][2][4]. This forward momentum ties back to their core mission of cultivating visionary startups that redefine industry landscapes and create lasting value.
LionBird was founded in 2012 by Haymi Behar (Advising Founder).
Key people at LionBird.
LionBird has more than 26 tracked investments across 18 companies. The latest tracked deal is $15.0M Series A in Rhino Health in May 2025.